指南与共识免疫规划卫生政策与健康促进

世界卫生组织美洲、非洲、东地中海、东南亚和西太平洋区域国家成人肺炎球菌疫苗接种的国家建议

National recommendations for adult pneumococcal vaccination in countries of the WHO regions of Americas, Africa, Eastern Mediterranean, South East Asia, and Western Pacific.
指南 / 共识 · Vaccine · 2024-09-29

该研究从国家官方网站、世界卫生组织门户及直接联系公共卫生官员等途径,收集了世界卫生组织五个区域161个国家成人肺炎球菌疫苗接种的国家指南。结果显示40.4%(65/161)的国家有可获得信息,其中63.1%(41/65)将成人肺炎球菌疫苗接种纳入国家疫苗接种规划,年龄推荐阈值在50至70岁之间。

要点

  • 161个国家中仅40.4%(65/161)有成人肺炎球菌疫苗接种信息可获取。
  • 有信息的65国中63.1%(41/65)将成人肺炎球菌疫苗接种纳入国家疫苗接种规划。
  • 基于年龄的接种推荐阈值在50至70岁之间。

核心结论

  • 五个世界卫生组织区域中不到一半的国家有成人肺炎球菌疫苗接种的可获取信息,所有被审查国家中仅25.5%(41/161)在国家疫苗接种规划中推荐成人肺炎球菌免疫接种。

研究设计与样本

  • 从国家官方网站和文件、世界卫生组织门户以及直接联系公共卫生官员、相关政府来源或当地疫苗接种专家收集世界卫生组织五个区域161个国家的成人肺炎球菌免疫接种国家指南。

主要发现

  • 40.4%(65/161)的国家有成人肺炎球菌疫苗接种信息可获取。
  • 有信息的65国中63.1%(41/65)将成人肺炎球菌疫苗接种纳入国家疫苗接种规划。
  • 纳入国家疫苗接种规划的41国中58.5%(24/41)同时推荐老年人和风险人群接种,9.8%(4/41)仅推荐老年人,31.7%(13/41)仅推荐风险人群。
  • 13个仅基于风险推荐的国家中30.8%(4/13)与年龄相关且严格保留给老年人。
  • 基于年龄的成人肺炎球菌疫苗接种推荐在东南亚、西太平洋和美洲区域似乎占主导,年龄阈值在50至70岁之间。

关键数值与推荐

  • 美洲区域有基于风险推荐的国家比例最高。
  • 这些国家中四分之三在推荐中纳入肺炎球菌结合疫苗(PCV)和肺炎球菌多糖疫苗(PPV23),多数按顺序接种。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Adults who are elderly or who have underlying health conditions are at particular risk of Streptococcus pneumoniae infections, and pneumococcal vaccines are available. Nonetheless, only national recommendations from countries of North America and Europe have been previously reviewed in the literature. METHODS: Consequently, we aimed to collate national guidelines for adult pneumococcal immunization across the 161 countries within the World Health Organization (WHO) regions-the Americas (except Canada and the United States of America), Africa, Eastern Mediterranean, South East Asia, and Western Pacific-from country-level official websites and documents, from the WHO portal, and from direct contact with public health officials, pertinent governmental sources, or local vaccination experts. RESULTS: For 40.4 % (65/161) of these countries, adult pneumococcal vaccination information was available. Among these 65 with available information, 63.1 % (41/65) include adult pneumococcal vaccination in the national vaccination schedule: 58.5 % (24/41) recommend vaccination both for older adults and for risk groups, while 9.8 % (4/41) recommend it only for older adults, and 31.7 % (13/41) only for risk groups. Of note, among the 13 national risk based-only recommendations, 30.8 % (4/13) are age-dependent and strictly reserved for older adults. The regions where age-based adult pneumococcal vaccination recommendations seem to predominate are South East Asia, Western Pacific, and the Americas. The threshold for age-based pneumococcal vaccination recommendations varies between 50 and 70 years of age. The Americas has the highest proportion of countries with risk-based recommendations. Three-quarters of these countries include PCV and PPV23 in the recommendations, most often given in sequence. CONCLUSIONS: Less than half of countries of the five WHO regions analyzed have accessible information on adult pneumococcal vaccination, and only 25.5 % (41/161) of all countries reviewed recommend adult pneumococcal immunization within the national vaccination schedule. Policymakers should consider extending pneumococcal vaccination guidelines-adapted to national priorities for adult healthcare-as based on local age demographics and risk factor predominance.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Fletcher MA, Vojicic J, Daigle D, et al. National recommendations for adult pneumococcal vaccination in countries of the WHO regions of Americas, Africa, Eastern Mediterranean, South East Asia, and Western Pacific. Vaccine. 2024. PMID: 39348774. doi:10.1016/j.vaccine.2024.126390

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。